clinical trial of ashwagandha kwath and therapeutic vomating procedure on thyroid level

CLINICAL EVALUATION OF ASHWAGANDHA KWATHA AND VAMANA KARMA ON THYROID PROFILE

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/01/022863

Enrollment

Registered

2020-01-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

Intervention1: ASHWAGANDHA KWATH FOLLOWED BY VAMAN KARMA : ASHWAGANDHA KWATH 40 ML ONCE IN A DAY ORALLY EMPTY STOMACH IN MORNING FOR 45 DAYS FOLLOWED BY VAMAN KARMA Intervention2: ASHWAGANDHA KWATH F

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with 6-20 IU TSH 2.Patients having clinical features of hypothyroidism 3.Patient fit for vaman karma as per classical text

Exclusion criteria

Exclusion criteria: 1.Pregnancy or lactation 2.Secondary Hypothyroidism 3.Patients having any other major complicated diseases like Diabetes mellitus, Cardiac disease, Tuberculosis, AIDS. 4.Patient unfit for Vamana karma as per classical text

Design outcomes

Primary

Measure	Time frame
THYROID PROFILETimepoint: 15th day,60th day,90th day	—

Secondary

Measure	Time frame
Dass 42 scaleTimepoint: 15thday,60th day,90th day	—

Countries

India

Contacts

Public ContactSUJATA KUMARI

CH BRAHM PRAKASH AYURVED CHARAK SANSTHAN

arun24@hotmail.com8178361290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026